Avantor, Inc. (NYSE:AVTR) Given Consensus Rating of “Reduce” by Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have earned a consensus rating of “Reduce” from the sixteen brokerages that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $10.5667.

Several equities analysts have commented on the stock. TD Cowen reiterated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Evercore set a $10.00 target price on shares of Avantor in a research report on Wednesday, February 11th. Morgan Stanley set a $10.00 price target on shares of Avantor in a research report on Friday, February 13th. Wall Street Zen lowered shares of Avantor from a “buy” rating to a “hold” rating in a research report on Saturday, May 30th. Finally, Jefferies Financial Group reaffirmed an “underperform” rating and set a $8.00 price target on shares of Avantor in a research report on Thursday, February 12th.

Avantor Price Performance

NYSE:AVTR opened at $9.10 on Thursday. Avantor has a one year low of $7.26 and a one year high of $15.93. The company has a market cap of $6.22 billion, a P/E ratio of -11.24, a P/E/G ratio of 5.21 and a beta of 0.97. The firm’s fifty day moving average price is $8.11 and its two-hundred day moving average price is $9.70. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the previous year, the company earned $0.23 earnings per share. The company’s quarterly revenue was up .0% on a year-over-year basis. Equities analysts expect that Avantor will post 0.79 earnings per share for the current year.

Insider Buying and Selling

In other Avantor news, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the completion of the purchase, the director directly owned 25,000 shares of the company’s stock, valued at $203,500. The trade was a ? increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Gregory T. Lucier purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was acquired at an average cost of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director directly owned 60,000 shares of the company’s stock, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 160,000 shares of company stock valued at $1,287,950. 0.28% of the stock is owned by insiders.

Institutional Trading of Avantor

Large investors have recently bought and sold shares of the company. Natixis Advisors LLC boosted its position in Avantor by 124.8% during the 3rd quarter. Natixis Advisors LLC now owns 1,907,077 shares of the company’s stock valued at $23,800,000 after acquiring an additional 1,058,617 shares in the last quarter. Quantbot Technologies LP lifted its position in Avantor by 1,333.0% during the third quarter. Quantbot Technologies LP now owns 246,494 shares of the company’s stock valued at $3,076,000 after buying an additional 229,293 shares during the period. Greenhaven Associates Inc. lifted its position in Avantor by 12.0% during the fourth quarter. Greenhaven Associates Inc. now owns 20,500,653 shares of the company’s stock valued at $234,937,000 after buying an additional 2,189,083 shares during the period. London Co. of Virginia purchased a new position in Avantor during the third quarter valued at $159,669,000. Finally, Invesco Ltd. lifted its position in Avantor by 0.8% during the third quarter. Invesco Ltd. now owns 16,053,368 shares of the company’s stock valued at $200,346,000 after buying an additional 119,508 shares during the period. 95.08% of the stock is owned by institutional investors.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.